|
Canadian Pharmacy |
|
|
|
 |
|
How can Lamital help treat Bipolar
I Disorder?
The US Food and Drug Administration (FDA) has approved Lamictal for the
maintenance treatment of adults with bipolar I disorder to delay the time
to occurrence of mood episodes includes depression, mania, hypomania, mixed
episodes in patients treated for acute mood episodes with standard therapy.
In the addition, the FDA has noted that findings for Lamictal were more
robust in bipolar depression. The effectiveness of Lamictal in the acute
treatment of mood episodes has not been established. FDA has approved Lamictal
as a first therapy which is used to maintain the disorder of bipolar
Lamictal gives long-term stability across the spectrum of mood episodes
associated with bipolar I disorder, with more robust findings in depression.
As you know, depressive episodes can be a significant clinical challenge.
Lamictal is said to be a long-term therapy which is convenient for you and
your patients as well. This medicine does not require any blood monitoring
and it also offers an easy plan of dosing.
Initiate as maintenance therapy at any phase of the illness in patients
treated for acute mood episodes with standard therapy. |
|
|
Lamictal Articles |
|
|
|
|
|
|
CUSTOMER SERVICE |
 |
 |
